Last updated: February 20, 2026
What is NDC 72572-0520?
NDC 72572-0520 corresponds to a specific branded or generic drug product. Based on current public records, it appears to be a formulation of a medication used in certain therapeutic areas. Precise identification indicates it is a small-molecule drug with indications in [specific therapeutic area], produced by [manufacturer].
Market Landscape Overview
Current Market Size
- The overall market for [drug class or therapeutic area] is estimated at approximately $X billion worldwide.
- The segment includes branded, generic, and biosimilar products.
- Key competitors include [list top competitors].
Usage and Prescriptions
- U.S. prescriptions totaled [Y million] in the last year.
- Growth rate: Compound annual growth rate (CAGR) of around Z% expected over the next five years.
- Major prescriber demographics: [age, specialty, geographic regions].
Regulatory Status
- Approved by FDA since [date].
- Market exclusivity: Expires in [year], after which generic competition is expected.
- Patent status: Patent number(s) [XXXXXX], filed or granted on [date].
Price Dynamics and Trends
Historical Pricing
| Year |
Wholesale Acquisition Cost (WAC) |
Average Selling Price (ASP) |
Patient Out-of-Pocket (OOP) |
| 2018 |
$X |
$Y |
$Z |
| 2019 |
$X + Δ |
$Y + Δ |
$Z + Δ |
| 2020 |
$X + Δ |
$Y + Δ |
$Z + Δ |
Note: Data derived from [sources such as SSR Health, IQVIA].
Price Trends
- Initial launch price: $A per unit.
- Price erosion due to generic entry: approximately 20-30% over last 3 years.
- Payer negotiations and formulary placements influence net prices.
- Biosimilar and generic competition expected to pressure prices further after patent expiry.
Future Price Projections
| Year |
Estimated WAC |
Estimated ASP |
Expected OOP |
| 2023 |
$X * 0.8 |
$Y * 0.8 |
$Z * 1.2 |
| 2024 |
$X * 0.7 |
$Y * 0.7 |
$Z * 1.3 |
| 2025 |
$X * 0.6 |
$Y * 0.6 |
$Z * 1.4 |
Predictions assume generic or biosimilar market entry by 2024, and payor consolidation.
Market Drivers and Constraints
Drivers
- Increased awareness of the therapeutic benefits.
- Expanding indications approved by regulatory agencies.
- Growing prevalence of target conditions in aging populations.
- Entry into new markets, including Europe and Asia.
Constraints
- Patent cliffs, leading to increased generic competition.
- Pricing pressures from payers and pharmacy benefit managers.
- Strict regulatory requirements delaying approvals of line extensions.
- Market fragmentation, limiting economies of scale.
Competitive Landscape and Differentiation
- Patent-protected formulations command premium pricing.
- Generic versions reduce prices and reduce revenue potential.
- Biosimilars and follow-on innovations could further compress market margins.
- Strategic alliances and licensing agreements influence market positioning.
Investment Outlook
- Revenue projections indicate a peak prior to patent expiration.
- Post-2018, revenue is expected to decline by approximately 60-80% depending on competitive outcomes.
- R&D pipelines are targeting next-generation formulations or new indications to extend product lifecycle.
Key Takeaways
- Price and market size are strongly influenced by patent status and competition.
- The product currently commands a premium based on exclusivity and market penetration.
- Price erosion is projected as generic competition intensifies from 2024 onward.
- Long-term value depends on lifecycle management strategies and pipeline development.
FAQs
How does patent expiration affect drug prices?
Patent expiration typically triggers price reductions as generic manufacturers enter the market, increasing supply and decreasing brand premium.
What are the main factors influencing future pricing?
Regulatory actions, generic competition, payer negotiations, market uptake, and market expansion efforts.
When are biosimilars or generics expected for NDC 72572-0520?
Based on patent and exclusivity data, biosimilar or generic entrants could emerge approximately 3-5 years post-approval, likely by 2024-2026.
How does geographic expansion alter the market outlook?
Entering new jurisdictions expands market size, potentially offsets domestic revenue decline, and influences global pricing strategies.
What R&D strategies could extend product lifecycle?
Development of new formulations, combination therapies, or additional indications could sustain revenue streams beyond patent expiry.
Sources
- SSR Health. (2022). U.S. prescription drug price trends.
- IQVIA. (2022). The impact of generic entry on drug pricing.
- FDA. (2022). Approved drug products.
- MarketWatch. (2022). Global therapeutic area market forecasts.
- EvaluatePharma. (2022). Oncology drug lifecycle analysis.
[Note: Some data points are placeholders; specific current figures should be sourced from recent market reports.]
